PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7
Abstract
Authors
S.J. Malkin D.G. Belbute B. Hunt C.S. Hoxer V. Martín